Balakrishna, V. A., A. Police, R. Hiremath, A. Raj, S. P. Sulochana, D. V. Chandrasekhar, Z. Mohd, R. K. Bhamidipati, and R. Mullangi. “Preclinical Assessment of Ulixertinib, a Novel ERK1/2 Inhibitor”. ADMET and DMPK, vol. 5, no. 4, Dec. 2017, pp. 212-23, doi:10.5599/admet.5.4.437.